Kenacort and Metformin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kenacort (triamcinolone) and Metformin (metformin hydrochloride). Common drug interactions include pancreatitis acute among males.

The phase IV clinical study analyzes what interactions people have when they take Kenacort and Metformin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Kenacort?

Kenacort has active ingredients of triamcinolone. eHealthMe is studying from 1,097 Kenacort users. Check the latest studies of Kenacort.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,354 Metformin users. Check the latest studies of Metformin.

On Jul, 10, 2026

13 people who take Kenacort and Metformin together, and have interactions are studied.

Kenacort and Metformin drug interactions.

What are the common drug interactions of Kenacort and Metformin, by gender? *:

female:

n/a

male:

Pancreatitis acute (sudden inflammation of pancreas)
Diabetes mellitus inadequate control
Malaise (a feeling of general discomfort or uneasiness)
Blindness
Disease progression
Drug resistance (reduction in effectiveness of a drug)
Fatigue (feeling of tiredness)
Secondary adrenocortical insufficiency (inadequate secretion of acth by the pituitary gland)
Visual acuity reduced (reduced clearness of vision)

What are the common drug interactions of Kenacort and Metformin, by age (0-1 to 60+)? *:

0-1:

Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Hypoglycaemia neonatal (deficiency of glucose in the bloodstream in neonatal)
Cryptorchism

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Secondary adrenocortical insufficiency (inadequate secretion of acth by the pituitary gland)

50-59:

Blindness

60+:

Pancreatitis acute (sudden inflammation of pancreas)
Diabetes mellitus inadequate control
Malaise (a feeling of general discomfort or uneasiness)
Disease progression
Drug resistance (reduction in effectiveness of a drug)
Fatigue (feeling of tiredness)
Visual acuity reduced (reduced clearness of vision)

What are the existing conditions these people have? *

Type 2 Diabetes: 8 people, 61.54%
Gastritis (inflammation of stomach): 7 people, 53.85%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 3 people, 23.08%
Secondary Hypothyroidism (pituitary gland and its failure to secrete tsh): 1 person, 7.69%
Retinitis (inflammation of the retina in the eye): 1 person, 7.69%
Hypogonadotropic Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries) due to a problem with the pituitary gland or hypothalamus): 1 person, 7.69%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Kenacort and Metformin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously